Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Sponsors
/ Sol-Gel Technologies, Ltd.
Sol-Gel Technologies, Ltd.
Industry · 15 registered clinical trials.
Status
Trial
Phase
Started
Active Not Recruiting
Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin
Gorlin Syndrome
Phase 3
2024-03-17
Completed
Evaluation of Topical Encapsulated Benzoyl Peroxide on the Skin Microbiome and Skin Biophysical Properties
Papulopustular Rosacea
Phase 1
2020-06-10
Terminated
Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)
Basal Cell Nevus Syndrome
Phase 3
2020-06-03
Terminated
An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Ce
Recurrent Basal Cell Carcinoma
Phase 2
2019-12-20
Completed
MUSE Study to Evaluate the Pharmacokinetics, Safety and Tolerability of S6G5T-3
Acne Vulgaris
Phase 1
2019-06-27
Completed
Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell
Basal Cell Nevus Syndrome
Phase 3
2019-02-19
Completed
Bioequivalence Study to Compare Sol-Gel Technologies' 5-FU Cream With Efudex® (5-FU) Cream
Actinic Keratosis (AK)
Phase 3
2018-12-21
Completed
A Study of S6G5T-3 in the Treatment of Acne Vulgaris
Acne Vulgaris
Phase 3
2018-12-21
Completed
A Study of S6G5T3 in the Treatment of Acne Vulgaris
Acne Vulgaris
Phase 3
2018-12-14
Terminated
A Long-Term Safety Study of S5G4T-1 in the Treatment of Papulopustular Rosacea
Papulopustular Rosacea
Phase 3
2018-09-12
Completed
A Study of S5G4T-1 in the Treatment of Papularpustular Rosacea
Papulopustular Rosacea
Phase 3
2018-06-21
Completed
A Study of S5G4T-1 in the Treatment of Papulopustular Rosacea
Papulopustular Rosacea
Phase 3
2018-06-18
Terminated
Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis
Tinea Pedis
Phase 2
2016-09-01
Completed
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
Acne Vulgaris
Phase 2
2016-05-01
Completed
A Study of DER 45-EV Gel to Treat Rosacea
Rosacea
Phase 2
2012-01-01